This morning, Johnson & Johnson shared its first-quarter performance.
Since its founding in 1886, the company has grown to become the world’s largest, most diversified healthcare products company, with more than 150,000 employees across the globe working every day to help change the trajectory of health for humanity.
“Johnson & Johnson reported another quarter of strong results across our business in the first quarter of 2023,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We remain focused on the successful separation of our Consumer Health business and are confident in the long-term growth prospects of our Pharmaceutical and MedTech businesses that continue to drive meaningful value for Johnson & Johnson shareholders.”
For more details about the company’s 2023 first-quarter results, and to read a message from Chairman of the Board and Chief Executive Officer Joaquin Duato, here’s an infographic that highlights key stats.
Johnson & Johnson’s 2023 Earnings
You are now leaving jnj.com
The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
